{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:00:52Z","timestamp":1771646452294,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ijcard.2010.10.041","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T04:25:49Z","timestamp":1290572749000},"page":"418-423","source":"Crossref","is-referenced-by-count":37,"title":["Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS\u2014A multicenter prospective controlled trial"],"prefix":"10.1016","volume":"155","author":[{"given":"Fatih","family":"Koc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurtulus","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Gungor","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Dogdu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Akif","family":"Vatankulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selim","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unal","family":"Erkorkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryem Ulku","family":"Aygul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihat","family":"Kalay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Kayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turgut","family":"Karabag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Alihanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur","family":"Gunebakmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2010.10.041_bb0005","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1056\/NEJMoa054209","article-title":"N-acetylcysteine and contrast-induced nephropathy in primary angioplasty","volume":"354","author":"Marenzi","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp050801","article-title":"Clinical practice. Preventing nephropathy induced by contrast medium","volume":"354","author":"Barrett","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine","volume":"343","author":"Tepel","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0020","doi-asserted-by":"crossref","first-page":"499.e1","DOI":"10.1016\/j.ahj.2007.11.042","article-title":"Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-a randomized controlled study","volume":"155","author":"Jo","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0025","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.106.687152","article-title":"Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies","volume":"115","author":"Briguori","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0002-9149(01)02243-3","article-title":"Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)","volume":"89","author":"Diaz-Sandoval","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0035","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0735-1097(02)02308-2","article-title":"Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure","volume":"40","author":"Shyu","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ehj.2003.11.016","article-title":"Standard vs double dose of N-acetylcysteine to prevent contrast agent-associated nephrotoxicity","volume":"25","author":"Briguori","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0045","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.ASN.0000116241.47678.49","article-title":"N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials","volume":"15","author":"Kshirsagar","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0050","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1523-1755.2004.00516.x","article-title":"Systematic review of the impact of N-acetylcysteine on contrast nephropathy","volume":"65","author":"Pannu","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-2-38","article-title":"Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis","volume":"2","author":"Bagshaw","year":"2004","journal-title":"BMC Med"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-148-4-200802190-00007","article-title":"Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy","volume":"148","author":"Kelly","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0065","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(03)00487-X","article-title":"A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study","volume":"41","author":"Baker","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0070","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ahj.2004.03.041","article-title":"A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect","volume":"148","author":"Webb","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jvs.2004.09.026","article-title":"Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine","volume":"40","author":"Rashid","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijcard.2006.04.023","article-title":"Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial","volume":"115","author":"Carbonell","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.289.5.553","article-title":"Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial","volume":"289","author":"Kay","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0095","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1046\/j.1523-1755.2002.00673.x","article-title":"A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography","volume":"62","author":"Durham","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0735-1097(02)01958-7","article-title":"Acetylcysteine and contrast agent-associated nephrotoxicity","volume":"40","author":"Briguori","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00270-005-0127-8","article-title":"The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity","volume":"29","author":"Sandhu","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ccd.10389","article-title":"Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast","volume":"58","author":"Boccalandro","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ehj.2003.11.011","article-title":"Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography: a randomized controlled trial and review of the current literature","volume":"25","author":"Goldenberg","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.ajkd.2004.01.010","article-title":"Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial","volume":"43","author":"Fung","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000077294","article-title":"Effect of N-acetylcysteine on serum creatinine concentration in patients with chronic renal insufficiency who are undergoing coronary angiography","volume":"4","author":"Agawal","year":"2004","journal-title":"Heart Drug"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0130","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ahj.2004.05.015","article-title":"N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up","volume":"148","author":"Miner","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0135","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1592\/phco.2005.25.8.1095","article-title":"N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?","volume":"25","author":"Shalansky","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2214\/AJR.07.2356","article-title":"I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity","volume":"189","author":"Poletti","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.ASN.0000107562.68920.92","article-title":"Nacetylcysteine in the prevention of radiocontrast-induced nephropathy","volume":"15","author":"Fishbane","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0150","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2214\/ajr.181.6.1811463","article-title":"Guidelines for contrast media from the European Society of Urogenital Radiology","volume":"181","author":"Thomsen","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0155","unstructured":"American College of Radiology. Manual on contrast media, version 5.0. (Accessed December 30, 2005, at http:\/\/www.acr.org\/s_acr\/sec.asp?CID=2131&DID=16687)."},{"key":"10.1016\/j.ijcard.2010.10.041_bb0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2215\/CJN.02580607","article-title":"Prevention of contrast-induced nephropathy with volume expansion","volume":"3","author":"Weisbord","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000066641","article-title":"A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity","volume":"93","author":"Trivedi","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.162.3.329","article-title":"Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty","volume":"162","author":"Mueller","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0175","first-page":"699","article-title":"Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study","volume":"15","author":"Krasuski","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP62001","article-title":"What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?","volume":"62","author":"Bader","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0185","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrastinduced nephropathy with sodium bicarbonate: a randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0190","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1503\/cmaj.1040847","article-title":"Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies","volume":"172","author":"Goldenberg","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0195","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2007.03443.x","article-title":"Review article: renal function assessment in cirrhosis-difficulties and alternative measurements","volume":"26","author":"Cholongitas","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijcard.2010.10.041_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical authorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527310008892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527310008892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T10:04:32Z","timestamp":1559815472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527310008892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0167527310008892"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.10.041","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}